Target Name: MIR765
NCBI ID: G768220
Other Name(s): Hsa-mir-765 | hsa-mir-765 | microRNA 765 | MicroRNA 765 | MIRN765 | mir-765 | hsa-miR-765

MIR765: A Potential Drug Target Or Biomarker for Cancer and Other Diseases

MIR765, also known as Hsa-mir-765, is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that are involved in various signaling pathways. One of the functions of MIR765 is to play a role in the development and progression of various diseases, including cancer.

Recent studies have identified MIR765 as a potential drug target or biomarker for several diseases, including cancer. One of the reasons for its potential as a drug target is its involvement in several signaling pathways that are involved in the development and progression of cancer. For example, MIR765 has been shown to be involved in the regulation of cell adhesion, which is a critical step in the development of cancer cells.

In addition, MIR765 has also been shown to be involved in the regulation of cell proliferation, which is another critical step in the development of cancer cells. Studies have shown that MIR765 can promote the growth and proliferation of cancer cells, and that inhibiting its activity may be an effective way to treat cancer.

Another potential drug target or biomarker for MIR765 is its role in the regulation of inflammation. MIR765 has been shown to be involved in the regulation of inflammation, and studies have shown that it can contribute to the development and progression of several inflammatory diseases, including cancer.

In addition, MIR765 has also been shown to be involved in the regulation of the blood-brain barrier, which is responsible for controlling the movement of substances into and out of the brain. Studies have shown that MIR765 can contribute to the development and progression of several brain diseases, including Alzheimer's disease, and that inhibiting its activity may be an effective way to treat these conditions.

Overall, MIR765 is a protein that has been shown to be involved in several important signaling pathways that are involved in the development and progression of various diseases, including cancer, inflammation, and brain diseases. As such, it is a potential drug target or biomarker for several diseases, and further research is needed to fully understand its role and potential as a therapeutic agent.

Protein Name: MicroRNA 765

More Common Targets

MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A